Tagged with Africa

MEA These 10 corporations represent 37% of the MEA market by value. Novo Nordisk’s USD 635M growth is mainly driven by Norditropin (somatropin), Victoza (liraglutide) & Saxenda (liraglutide) which have grown at 60%, 18% and 190% PPG respectively. Hikma’s USD 497M growth has been the fastest due to Remox (amoxicillin) and…

Morocco Spanish plasma specialist Grifols is making a move to invest in Africa, and was recently selected as the supplier for Soludia Maghreb’s new plant in Morocco. The CEOs of both companies see the deal as the first step in a long-term collaboration.    Grifols, founded in Barcelona in 1940, is…

Egypt Dr Hany Mashaal, general manager for Egypt and the Rest of Middle East for Sun Pharma, explains the importance of Egypt for the Indian company, having recently opened a manufacturing facility in the country. He highlights the need for a faster drug registration process and gives an outlook at the…

Opinion Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11 months old. Here she provides insights on where South Africa is at in terms of rare diseases and what needs…

Algeria Moncef Meklati, Merck’s general manager for North West Africa, discusses the company’s ambitions in the region, the key to successful joint ventures and evolving attitudes to chronic diseases in Algeria.   From the first day I started working for Merck, I’ve been impressed by the strong commitment of my team…

Algeria Doria Oughlis, Lilly’s GM for North West Africa, outlines the company’s historic presence in Algeria, current priorities and Lilly’s overarching contribution to the health of the region.   Could you please start by describing Lilly’s legacy in Algeria to date? Lilly’s presence in Algeria actually long predates the setting up…

Pharma Legal Handbook Structured legal guide to cannabinoid drugs, medicinal cannabis and opioid drugs in South Africa. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma Legal Handbook: South Africa, available to purchase here for USD 99.   CANNABINOID DRUGS 1. Are Cannabinoid Drugs authorized in…

Pharma Legal Handbook Regulatory reforms in South African Pharma – a comprehensive legal overview. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma Legal Handbook: South Africa, available to purchase here for USD 99.   1. Are there proposals for reform or significant change to the…

Pharma Legal Handbook The ins and outs of patents and trademarks in South African Pharma. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma Legal Handbook: South Africa, available to purchase here for USD 99.   1. What are the basic requirements to obtain patent and…

Pharma Legal Handbook The key facts about product liability in South African Pharma. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma Legal Handbook: South Africa, available to purchase here for USD 99.   1. What types of liability are recognized in your jurisdiction? In…

Pharma Legal Handbook Traditional medicines & OTC products in South Africa – a legal guide. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma Legal Handbook: South Africa, available to purchase here for USD 99.   1. What are the regulatory requirements for traditional, herbal,…

Pharma Legal Handbook All legal aspects of marketing, manufacturing, packaging, labeling and advertising of drugs in South Africa. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma Legal Handbook: South Africa, available to purchase here for USD 99.   1. What is the authorization process…